Natural Sciences
Life Sciences
Scientific Computing
Back    
January 11 2018 / 18:00 PM

Category:
Life Science

Lecturer:
Dr. Giorgio G. Galli, Novartis, Basel, Switzerland

Place:
BioQuant, SR041, Im Neuenheimer Feld 267

Host:
BioSpectives

Description:
From industry to academia and back Contact details: biospective@gmx.de spective Giorgio Galli graduated from the University of Milan with a B.Sc. degree in Industrial and environmental biotechnology in 2005. Upon obtaining an M.Sc. degree in Functional genomics and bioinformatics from the same University he moved to the Biotech Research and Innovation Centre of Copenhagen, where he obtained his Ph.D. degree in Molecular Biomedicine in 2012. The focus of his Ph.D. thesis was the characterization of the molecular functions of the transcriptional regulator PRDM5 in-vivo. From 2012 to 2015 he was a Post-doctoral fellow at Harvard University. He worked at the Department of Stem Cell and Regenerative Biology at the Boston Children’s Hospital. His research was focused on characterization of the mechanisms by which the Hippo signaling pathway signals to the chromatin during oncogenetic transformation. Currently he is a laboratory head at the Novatis Institute for Biomedical Research in Basel. His laboratory uses functional genomic approaches to identify proteins with oncogenic functions and performs molecular characterization of the identified hits. In addition, he is a project team leader for a drug-discovery biology program and coordinator of the global team for drug discovery programs on a class of “undruggable targets”. During his talk Dr. Galli will discuss his career steps starting from an internship in a pharmaceutical company, transitioning to academia and back into industry as a laboratory head in a big pharmaceutical company. Through his insight, he will discuss possible pros and cons of each environment and the train of thought behind each transition. Moreover, he will describe how cancer research is approached in the industry, starting from basic disease characterization up to the drug discovery pipelines.

Event data:
Import event data into Outlook Calendar